The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Clinical Chemistry Global Market Report 2023, the clinical chemistry market is expected to show significant growth in the forecast period.

Key insights from the clinical chemistry market forecast include:

1. Market Size

The global clinical chemistry market is expected to grow from $12.84 billion in 2022 to $13.7 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The market size of global clinical chemistry is expected to grow to $17.48 billion in 2027 at a CAGR of 6.3%.

2. Major Driver

Growing chronic disease rates propel clinical chemistry market. Chronic diseases last a year or more, require ongoing care, and limit daily activities. They are top global causes of death and disability, including diabetes, cancer, and heart disease. Clinical chemistry enhances illness detection and risk assessment, supporting initiatives like flu and infectious disease monitoring. In September 2020, an American Action Forum study reported rising chronic illness frequency and costs in the United States, with continued growth expected, costing about 19.6% of GDP annually. Hence, increased chronic disease prevalence drives clinical chemistry market growth.

View More On The Clinical Chemistry Market Report 2023 – https://www.thebusinessresearchcompany.com/report/clinical-chemistry-global-market-report

3. Key Trend

Tech advances drive clinical chemistry market growth. Major firms adopt innovations for market strength. For example, in July 2021, Vanderbilt University’s Core Clinical Chemistry Lab launched a faster, higher-volume automated chemistry line, doubling daily test capacity.

4. Largest Region

North America was the largest region in the chemical chemistry market in 2022.

5. Major Players

Major players in the clinical chemistry market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., ELITech Group, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics, Diatron Mi Apac Private Limited, Nova Biomedical Corporation, Johnson & Johnson Services Inc., Alfa Wassermann Inc., HORIBA Ltd., Mindray Medical International Ltd., Randox Laboratories Ltd., and SYNLAB International GMBH.

Request A Sample Of The Global Clinical Chemistry Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7630&type=smp

Key Clinical Chemistry Market Segments
The global clinical chemistry market is segmented –
1) By Product: Analyzers, Reagents And Consumables
2) By Application: General Chemistry Test, Liver Function Test, Kidney Function Test, Urinalysis, Electrolyte Panel, Lipid Profile, Specialty Chemical Test, Other Applications
3) By End User: Hospitals, Diagnostic Or Pathology Centers, Ambulatory Surgery Centers, Other End Users

The Clinical Chemistry Global Market Report 2023  provides an in-depth analysis on the clinical chemistry market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the clinical chemistry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
In Vitro Diagnostics Global Market Report 2023
Veterinary Diagnostic Equipment Global Market Report 2023
Retail Clinics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model